Laurion Capital Management LP Krystal Biotech, Inc. Transaction History

Laurion Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$27.2 - $41.2 $1.02 Million - $1.54 Million	-37,383 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$19.86 - $32.9 $401,430 - $665,007	20,213 Added 117.72%	37,383 $1.23 Million
Q4 2018 Feb 14, 2019	BUY	$15.03 - $25.38 $258,065 - $435,774	17,170 New	17,170 $357,000

300

24.3M

388K

233K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.84B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.